Corrigendum to: Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancer

Neuro Oncol. 2021 Dec 1;23(12):2123. doi: 10.1093/neuonc/noab204.

Weijun Wang¹, Haiping He^{2

3}, Nagore I Marín-Ramos¹, Shan Zeng^{2

3}, Steven D Swenson¹, Hee-Yeon Cho¹, Jie Fu³, Paul M Beringer^{4

5}, Josh Neman^{1

6

7}, Ligang Chen^{2

3}, Axel H Schönthal⁸, Thomas C Chen^{1

6

7}

¹ Department of Neurological Surgery, University of Southern California, Los Angeles, California, USA.
² Department of Neurosurgery, Luzhou, China.
³ Department of Neurology Affiliated Hospital of Southwest Medical University, Luzhou, China.
⁴ Department of Clinical Pharmacy, Los Angeles, California, USA.
⁵ School of Pharmacy, University of Southern California, Los Angeles, California, USA.
⁶ Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, USA.
⁷ Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
⁸ Department of Microbiology and Immunology, University of Southern California, Los Angeles, California, USA.

No abstract available

Publication types